Skip to main content

Cancer Prevenpinon in the Developing World: Mission Impossible?

  • Conference paper
Cancer Prevention II

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 181))

Abstract

Abstract Cancer is set to become the newest epidemic in the developing world. This fact is still largely unknown. The UICC, therefore, has been acting in order to inform policymakers, with the aim of pushing them to act in order to tackle this looming disaster. The implementation of a cancer control plan, encompassing prevention, screening and treatment in each country, should therefore become the declared goal of all health policymakers worldwide.

Today cancer kills more people worldwide than human immunodeficiency virus (HIV), tuberculosis (TB) and malaria combined (see Fig. 3. 1 ). This fact is largely unknown not only within the lay press but to some extent even in the scientific community. This might be one of the reasons' even while governments and international agencies give much attention to e.g. HIV and malaria-that cancer is seldom mentioned.

Neoplastic diseases are sometimes also thought to be a hallmark of the developed world, while on the contrary cancer is set to become the newest epidemic in the developing world.

Based on the most recently estimated incidence rates, the 11 million cancer cases diagnosed in 2002 will reach roughly 17 million in 2020 and 27 million by 2050 [1]. These estimates assume no change in the risk pattern of cancer incidence. As shown in Fig. 3. 2 , a yearly increase of 1% of the risk would add at least another million cases per year [2]. Close to twothirds of the cancer cases expected for 2050 will most probably occur in low-income countries: since the cure rate there is much lower than in the high-income countries, the difference in mortality will be even more pronounced. In fact, it has been predicted that already by 2020 almost two-thirds of cancer deaths will occur in developing countries, and this proportion could reach three-quarters around 2050 [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Bray F, Moller B (2006) Predicting the future burden of cancer. Nat Rev Cancer 6:63–74

    Article  PubMed  CAS  Google Scholar 

  3. Cavalli F (2006) Cancer in the developing world: can we avoid the disaster? Nat Clin Pract Oncol 3:582–583

    Article  PubMed  Google Scholar 

  4. Danaei G, Vander Hoorn S, Lopez AD, et al (2005) Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366:1784–1793

    Article  PubMed  Google Scholar 

  5. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044

    Article  PubMed  CAS  Google Scholar 

  6. Colditz GA, Sellers TA, Trapido E (2006) Epidemiology-identifying the causes and pre-ventability of cancer. Nat Rev Cancer 6:75–83

    Article  PubMed  CAS  Google Scholar 

  7. Tanneberger S, Cavalli F, Pannuti F (2003) Cancer in developing countries—the great challenge for oncology in the 21st century. Zuckschwerdt Verlag, Germering/München

    Google Scholar 

  8. Sebrié E, Glantz SA (2006) The tobacco industry in developing countries forestalled legislation on tobacco control. BMJ 332:313–314

    Article  PubMed  Google Scholar 

  9. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al (2005) Cost-effectiveness of cervical cancer screening in five developing countries. N Engl J Med 353:2158–2168

    Article  PubMed  CAS  Google Scholar 

  10. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Orthod 24:2137–2149

    Google Scholar 

  11. Ribeiro RC, Pui CH (2005) Saving the children—improving childhood cancer treatment in developing countries. N Engl J Med 352:2158

    Article  PubMed  CAS  Google Scholar 

  12. Tirelli U, de Castro G Jr, Awada A (2006) Reimbursement for molecularly targeted anticancer agents (keynote comment). Lancet Oncol 7:2–3

    Article  PubMed  Google Scholar 

  13. World Health Organization (2005) The 58th World Health Assembly adopts resolution on cancer prevention and control. http://www.who. int/mediacentre/news/releases/2005/pr_wha05/ en/index.html. Cited 18 August 2006

  14. Yang G, Ma J, Liu N, Zhou L (2002) Smoking and passive smoking in Chinese. Chin J Epidemiol 26:77–83

    Google Scholar 

  15. Burton A (2006) The UICC My child matters initiative awards: combating cancer in children in the developing world. Lancet Oncol 7:13–14

    Article  PubMed  Google Scholar 

  16. UICC (2008) World Cancer Campaign homepage. http://www.worldcancercampaign.org. Cited 1 Jun 2008

  17. Key T (2007) Diet and the risk of cancer—new report shows obesity and alcohol are the strongest risk factors (editorial). BMJ 335:897

    Article  PubMed  Google Scholar 

  18. Boffetta P, Nyberg F (2003) Contribution of environmental factors to cancer risk. Br Med Bull 68:71–94

    Article  PubMed  CAS  Google Scholar 

  19. UICC (2008) World Cancer Declaration. http:// www.uicc.org/index.php?option=com_content &task=view&id=14227&Itemid=356. Cited 1 Jun 2008

  20. AfrOx (2008) London Declaration (updated 21 Feb 2008). http://www.afrox.org/declaration. html. Cited 1 Jun 2008

  21. International Atomic Energy Agency (2004) IAEA creates “PACT” fundraising fund to fight cancer. IAEA, Vienna. http://www.iaea.org/ News Center/News/2004/pact.html. Cited 1 Jun 2008

  22. Perz JF, Armstrong GL, Farrington LA, et al (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Hepatology 45:529–538

    Article  Google Scholar 

  23. Roden R, Wu TC (2006) How will HPV vaccines affect cervical cancer? Nat Rev Cancer 6:753–763

    Article  PubMed  CAS  Google Scholar 

  24. Agosti JM, Goldie SJ (2007) Introducing HPV vaccine in developing countries—key challenges and issues. N Engl J Med 356:1908–1910

    Article  PubMed  CAS  Google Scholar 

  25. Sankaranarayanan R, Gaffikin L, Jacon M, et al (2005) A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 89[Suppl 2]:S4–S12

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franco Cavalli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Cavalli, F. (2009). Cancer Prevenpinon in the Developing World: Mission Impossible?. In: Senn, HJ., Kapp, U., Otto, F. (eds) Cancer Prevention II. Recent Results in Cancer Research, vol 181. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69297-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69297-3_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69296-6

  • Online ISBN: 978-3-540-69297-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics